Overview Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia. Status: Completed Trial end date: 2003-07-01 Target enrollment: Participant gender: Summary This purpose of this study is to assess the efficacy and safety of Ramelteon, once daily (QD), in elderly subjects with chronic insomnia. Phase: Phase 3 Details Lead Sponsor: Takeda